NOXXON Pharma's Series D Round

NOXXON Pharma raised a round of funding on May 19, 2010.

NOXXON Pharma is a clinical-stage biopharmaceutical company whose core focus is on improving cancer treatment by targeting the tumor microenvironment. NOXXON's goal is to significantly enhance the eff…

Articles about NOXXON Pharma's Series D Round: